Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Kakali De und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Gonadotropin-Releasing Hormone, Doxorubicin, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India.
- Netaji Subhas Chandra Bose Cancer Hospital, 3081 Nayabad, Kolkata 700094, India.
ORCID-Profile: Kakali De, S K Eashayan Tanbir
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
De, K., Tanbir, S. K. E., Sinha, S., & Mukhopadhyay, S. (2024). Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00528
Vancouver
De K, Tanbir SKE, Sinha S, Mukhopadhyay S. Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00528
BibTeX
@article{De2024,
author = {De, Kakali and Tanbir, S K Eashayan and Sinha, Samarendu and Mukhopadhyay, Soma},
title = {Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00528}
}
EUVIMED